D.C. Act 26-416 · Section 5132
Section 5132 (no heading in source)
Before/After explanation not reviewed yet. The official section text is available below; a legal comparison will be added only after source review.
Enacted 2026-08-13 · Effective 2026-08-13 · Emergency act.
Historical enacted record. Complete current-law and later-development review may be unfinished.
Official section text
5132 Section 5012 of the Opioid Abatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C. Law 24-167; D.C. Official Code § 7-3221), is amended by adding a new subsection (b-7) to read as follows: (b-7) Notwithstanding any other provision of this subtitle, in Fiscal Year 2027, a total of $796,000 from the Fund shall be used for the following purposes: (1) $400,000 to the Office of the Chief Medical Officer for the purpose of enabling the testing of illicit drug misuse and the development of novel testing methods for opioids within the agency's Forensic Toxicology Lab and Data Fusion Center; and (2) $396,000 for a grant to a District-based children's hospital operating an evidence-based adolescent substance use disorder treatment program that provides developmentally appropriate clinical care, peer recovery support, family-centered services, and community-based treatment for children, adolescents, and young adults with substance use disorders, particularly in underserved areas of the District. .